This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erickson, K. D.
Right arrow Articles by Martin, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erickson, K. D.
Right arrow Articles by Martin, J. M.

 Previous Article

Journal of Virology, January 2000, p. 1057-1060, Vol. 74, No. 2
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

The Late Lytic LMP-1 Protein of Epstein-Barr Virus Can Negatively Regulate LMP-1 Signaling

Kimberly D. Erickson and Jennifer M. Martin*

Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado 80309

Received 16 August 1999/Accepted 8 October 1999

The BNLF-1 open reading frame of Epstein-Barr virus (EBV) encodes two related proteins, latent membrane protein-1 (LMP-1) and lytic LMP-1 (lyLMP-1). LMP-1 is a latent protein required for immortalization of human B cells by EBV, whereas lyLMP-1 is expressed during the lytic cycle and is found in the EBV virion. We show here that, in contrast to LMP-1, lyLMP-1 is stable, with a half-life of >20 h in tetradecanoyl phorbol acetate- and butyrate-treated B95-8 cells. Although lyLMP-1 itself has negligible effects on NF-kappa B activity, it inhibits NF-kappa B activation by LMP-1 in a dose-dependent manner. The lyLMP-1 protein does not oligomerize with LMP-1, and the negative effect of lyLMP-1 on NF-kappa B activation by LMP-1 does not result from lyLMP-1-mediated disruption of LMP-1 oligomers. Modulation of LMP-1-activated signaling pathways is the first identified biological activity associated with lyLMP-1, and this activity may contribute to the progression of EBV's lytic cycle.


* Corresponding author. Mailing address: Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Box 347, Boulder, CO 80309. Phone: (303) 492-6346. Fax: (303) 492-1587. E-mail: jm{at}stripe.colorado.edu.


Journal of Virology, January 2000, p. 1057-1060, Vol. 74, No. 2
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Pandya, J., Walling, D. M. (2006). Oncogenic Activity of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Is Down-Regulated by Lytic LMP-1.. J. Virol. 80: 8038-8046 [Abstract] [Full Text]  
  • Ahsan, N., Kanda, T., Nagashima, K., Takada, K. (2005). Epstein-Barr Virus Transforming Protein LMP1 Plays a Critical Role in Virus Production. J. Virol. 79: 4415-4424 [Abstract] [Full Text]  
  • Xie, P., Bishop, G. A. (2004). Roles of TNF Receptor-Associated Factor 3 in Signaling to B Lymphocytes by Carboxyl-Terminal Activating Regions 1 and 2 of the EBV-Encoded Oncoprotein Latent Membrane Protein 1. J. Immunol. 173: 5546-5555 [Abstract] [Full Text]  
  • Pandya, J., Walling, D. M. (2004). Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Half-Life in Epithelial Cells Is Down-Regulated by Lytic LMP-1. J. Virol. 78: 8404-8410 [Abstract] [Full Text]  
  • De Francesco, M. A., Gargiulo, F., Esteban, P., Calzavara-Pinton, P. G., Venturini, M., Perandin, F., Baronio, M., Pollara, C., Terlenghi, L., Manca, N. (2004). Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides. J Med Microbiol 53: 381-387 [Abstract] [Full Text]  
  • Edwards, R. H., Sitki-Green, D., Moore, D. T., Raab-Traub, N. (2004). Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma. J. Virol. 78: 868-881 [Abstract] [Full Text]  
  • Vazirabadi, G., Geiger, T. R., Coffin, III, W. F., Martin, J. M. (2003). Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 84: 1997-2008 [Abstract] [Full Text]  
  • Dirmeier, U., Neuhierl, B., Kilger, E., Reisbach, G., Sandberg, M. L., Hammerschmidt, W. (2003). Latent Membrane Protein 1 Is Critical for Efficient Growth Transformation of Human B Cells by Epstein-Barr Virus. Cancer Res. 63: 2982-2989 [Abstract] [Full Text]  
  • Mahot, S., Sergeant, A., Drouet, E., Gruffat, H. (2003). A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. 84: 965-974 [Abstract] [Full Text]  
  • Erickson, K. D., Berger, C., Coffin, W. F. III, Schiff, E., Walling, D. M., Martin, J. M. (2003). Unexpected Absence of the Epstein-Barr Virus (EBV) lyLMP-1 Open Reading Frame in Tumor Virus Isolates: Lack of Correlation between Met129 Status and EBV Strain Identity. J. Virol. 77: 4415-4422 [Abstract] [Full Text]  
  • Coffin, W. F. III, Geiger, T. R., Martin, J. M. (2003). Transmembrane Domains 1 and 2 of the Latent Membrane Protein 1 of Epstein-Barr Virus Contain a Lipid Raft Targeting Signal and Play a Critical Role in Cytostasis. J. Virol. 77: 3749-3758 [Abstract] [Full Text]  
  • Busch, L. K., Bishop, G. A. (2001). Multiple Carboxyl-Terminal Regions of the EBV Oncoprotein, Latent Membrane Protein 1, Cooperatively Regulate Signaling to B Lymphocytes Via TNF Receptor-Associated Factor (TRAF)-Dependent and TRAF-Independent Mechanisms. J. Immunol. 167: 5805-5813 [Abstract] [Full Text]  
  • Brennan, P., Floettmann, J. E., Mehl, A., Jones, M., Rowe, M. (2001). Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative. J. Biol. Chem. 276: 1195-1203 [Abstract] [Full Text]